Any and all statements made in the ISODIOL blog in regard to Cannabinoid products are not expressed as medical claims. Our intention is to educate, not to suggest results nor to encourage action on the part of the reader. ISODIOL is not responsible for, and expressly disclaims all liability for, damages of any kind arise out of use, refrence to, or reliance on any information contained within the site. The information contained within the site is periodically updated, there is no gurantee to the accuracy of the information. Nothing on this site is intended to operate as legal advice, please seek your own legal advice.
The only way you’re going to know if CBD isolate is right for you is to give it a try. Unlike other methods of cannabis consumption, CBD isolate can be taken in many different ways. That makes it incredibly versatile for those who need CBD’s medicinal properties at work or out in public. A small pinch in pretty much anything will get you the relief you need.
That leaves those touting CBD’s effectiveness pointing primarily to research in mice and petri dishes. There, CBD (sometimes combined with small amounts of THC) has shown promise for helping pain, neurological conditions like anxiety and PTSD, and the immune system—and therefore potentially arthritis, diabetes, multiple sclerosis, cancer, and more.
The reason so many people are interested in cannabis products that don’t make them high, proponents say, is that CBD helps with everything from pain and nausea to rheumatoid arthritis, cancer, Crohn’s disease, and dementia. CBD is anti-inflammatory, anti-anxiety, antibacterial, immunosuppressive, and more, says Joseph Cohen, D.O., a cannabis doctor in Boulder, CO.
On the other hand, marijuana-derived CBD and anything else derived from a cannabis plant was still classified by the DEA as a Schedule I drug (defined as a drug with "no currently accepted medical use and a high potential for abuse") until October 2018. In 2016, the DEA stated that all extracts containing more than one cannabinoid would remain classified as Schedule I. However, the approval of Epidiolex had an influence in changing this, and prescription CBD drugs with a THC content of below 0.1% have now been reclassified as Schedule 5, the lowest rating.
A study published by the Lautenberg Center for Immunology and Cancer Research, which aimed its focus on the effectiveness of CBD isolate compared to full-plant extract, supported this concept, stating in its summary that "in all of the tests, the isolated CBD was ineffective both before and after a certain dosage, while the effectiveness of the full-spectrum solution continued to increase as higher doses were administered. The results all indicate that CBD is only effective against swelling and pain at a certain dose, and that cannabis solutions containing a full range of cannabinoids will continue to provide corresponding effects as the dosage is increased."
For our review of the best CBD topicals available online, we focused only on companies which make third-party, independent lab results available to consumers. Lab results are available online, included in the order, or on request. It’s vitally important that consumers know exactly what products they’re consuming: how strong it is, and whether it has any impurities. We also focused on brands with fast, friendly customer service and easy to use websites.